Real-time 3-Dimensional Echocardiography for Assessment of Cardiac Function and Congenital Heart Disease (3DE-CHD)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01300221 |
Recruitment Status
:
Withdrawn
(Study did not receive IRB approval.)
First Posted
: February 21, 2011
Last Update Posted
: September 5, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Congenital Heart Disease |

Study Type : | Observational |
Actual Enrollment : | 0 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Real-time 3-Dimensional Echocardiography for Assessment of Cardiac Function and Congenital Heart Disease |
Study Start Date : | February 2011 |
Actual Primary Completion Date : | February 2011 |
Actual Study Completion Date : | March 2011 |

Group/Cohort |
---|
Group 1
Subjects who are healthy normal children.
|
Group 2
Subjects who have congenital heart disease.
|
Group 3
Subjects who have sickle cell disease
|
Group 4
Subjects who have Duchenne muscular dystrophy
|
Group 5
Patients who have Marfan syndrome and other aortic disease
|

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 19 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Subjects with diagnosis that fits into Group 1 to 5 and who are willing to participate (consent/assent obtained)
- Do not meet the exclusion criteria (as follows).
Exclusion Criteria:
- Unwilling to participate or give consent.
- Clinically unstable.
- Unable to co-operate.
- Poor acoustic windows.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01300221
United States, Pennsylvania | |
Drexel University College of Medicine/St. Christopher's Hospital for Children | |
Philadelphia, Pennsylvania, United States, 19140 |
Principal Investigator: | Shuping Ge, MD | Drexel University College of Medicine/St. Christopher's Hospital for Children |
Responsible Party: | Drexel University |
ClinicalTrials.gov Identifier: | NCT01300221 History of Changes |
Other Study ID Numbers: |
H-16888 |
First Posted: | February 21, 2011 Key Record Dates |
Last Update Posted: | September 5, 2013 |
Last Verified: | September 2013 |
Keywords provided by Drexel University:
Three dimension echocardiography Congenital heart disease Z-score |
Additional relevant MeSH terms:
Heart Diseases Heart Defects, Congenital Cardiovascular Diseases Cardiovascular Abnormalities Congenital Abnormalities |